Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 45(3): 216-221, Mar. 2012. ilus, tab
Artigo em Inglês | LILACS | ID: lil-618044

RESUMO

Evaluating the activity of the complement system under conditions of altered thyroid hormone levels might help elucidate the role of complement in triggering autoimmune processes. Here, we investigated alternative pathway (AP) activity in male Wistar rats (180 ± 10 g) after altering their thyroid hormone levels by treatment with triiodothyronine (T3), propylthiouracil (PTU) or thyroidectomy. T3 and thyroxine (T4) levels were determined by chemiluminescence assays. Hemolytic assays were performed to evaluate the lytic activity of the AP. Factor B activity was evaluated using factor B-deficient serum. An anti-human factor B antibody was used to measure factor B levels in serum by radial immunodiffusion. T3 measurements in thyroidectomized animals or animals treated with PTU demonstrated a significant reduction in hormone levels compared to control. The results showed a reduction in AP lytic activity in rats treated with increasing amounts of T3 (1, 10, or 50 µg). Factor B activity was also decreased in the sera of hyperthyroid rats treated with 1 to 50 µg T3. Additionally, treating rats with 25 µg T3 significantly increased factor B levels in their sera (P < 0.01). In contrast, increased factor B concentration and activity (32 percent) were observed in hypothyroid rats. We conclude that alterations in thyroid hormone levels affect the activity of the AP and factor B, which may in turn affect the roles of AP and factor B in antibody production.


Assuntos
Animais , Masculino , Ratos , Antitireóideos/farmacologia , Fator B do Complemento/metabolismo , Via Alternativa do Complemento/efeitos dos fármacos , Propiltiouracila/farmacologia , Tiroxina/sangue , Tri-Iodotironina/sangue , Via Alternativa do Complemento/fisiologia , Hipertireoidismo/sangue , Hipertireoidismo/induzido quimicamente , Hipertireoidismo/imunologia , Hipotireoidismo/sangue , Hipotireoidismo/induzido quimicamente , Hipotireoidismo/imunologia , Medições Luminescentes , Ratos Wistar , Tireoidectomia
2.
Braz. j. med. biol. res ; 28(5): 585-9, May 1995. tab, graf
Artigo em Inglês | LILACS | ID: lil-154880

RESUMO

Immunoglobulin Fc receptors (FcRs), present in Trypanosomatidae pathogenic for mammals, may be a mechanism by which these parasites escape the host immune response. We studied the possible role of these receptors in evasion by the alternative complement pathway. Promastigotes of Leishmania amazonensis and trypsinized trypomastigotes of Trypanossoma cruzi treated with heat-aggregated normal gamma globulin and then incubated with fresh normal guinea pig serum were shown to be more resistant to lysis. When compared to log phase Leishmania promastigotes, this resistance was at least 4.5-fold greater in parasites harvested in the stationary growth phase EDTA and egta PLUS MgCl2 inhibited the cytotoxic effect of serum, suggesting the participation of the alternative complement pathway. The distribution of FcRs among genera of Trypanosomatidae that arepathogenic, infective or noninfective for mammals and their affinity for mammalian and fowl immunoglobulin were also examined. These receptors ara presented only in species infective or pathogenic for mammals, a finding that suggests that this structure is essential for the establishment of infection but in not necessarily a virulence factor. Further more, the ligand specificity is limited to the immunoglobulin of mammalian but not of fowl origin


Assuntos
Animais , Via Alternativa do Complemento/fisiologia , Fragmentos Fc das Imunoglobulinas/fisiologia , Trypanosomatina/imunologia , Formação de Roseta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA